Background Community pharmacists are expanding their sphere of activity within primary health care, increasing their role not only in health care but also research.
Introduction
Pharmacists can make an important contribution to public health by improving access to emergency hormonal contraception (EHC). 1 UK health authorities saw the Crown report's recommendation regarding introduction of patient group directions (PGDs) as an opportunity for community pharmacists to supply EHC free of charge. 2 This was supported by funding from Health Action Zone (HAZ) schemes, set up in areas of deprivation across the UK to address health inequalities, 3,4 which encourage health care providers to find innovative and collaborative ways of increasing health gain. 5 In January 2001, following establishment of the PGD schemes, levonorgestrel EHC (Levonelle ® ) was deregulated to a pharmacy (P) status in the UK and became available in all community pharmacies. The PGD services provided EHC free of charge, while other pharmacies charged a fee (£24.99 in 2008). Since deregulation, women have shown increasing preference for pharmacy over clinical provision of EHC. 6 The expansion of pharmacists' roles into sexual health has been accompanied by research to evaluate these developments. Methods used to assess pharmacy EHC supply have included questionnaire surveys, focus groups and mystery shopper studies. 7, 8 Some studies have used population-based samples; 9 others have recruited through pharmacists at the point of provision. 10
Conclusions As pharmacists expand their role, training and professional development will need to be enhanced to support them in their contribution to health care and research. In this paper we describe some methodological difficulties encountered in a pilot study investigating women's experience of obtaining EHC through pharmacies and clinical services. We discuss how these difficulties threatened continuation and validity of the research to help mitigate the risk of similar problems impeding future research in this important area.
Keywords

Emergency contraception study
The methodology of this pilot study is described fully elsewhere. 11 We recruited a cohort of women obtaining EHC through two types of services between 2002 and 2003 in the inner city South London boroughs of Lambeth and Southwark, with the aim of investigating short-term impact within different service models. We asked medical staff and pharmacists to recruit women at the time they presented. Willing volunteers recorded their contact details on an information sheet and were contacted and interviewed 4 months later. Of the five pharmacies taking part in the study, two were involved in the HAZ scheme and three were selling EHC over the counter (attendance was lower at these premises compared to the HAZ pharmacies). 2 Pharmacists were paid for their time and none refused involvement.
Methodological issues
Many of the pharmacists were familiar with audit, but few had participated in clinical research. A key challenge related to sample recruitment and response rates. We could not recruit directly from HAZ pharmacies as the contract held with local health authorities prohibited third-party disclosure of information. Instead the pharmacists themselves agreed to recruit on our behalf. However, most were unable to record numbers approached to participate because of the demands of business and so we had no denominator for the response rate.
A second difficulty related to speed of recruitment. In pharmacies selling EHC over the counter, study enrolment was slow because fewer women were buying from this source. The HAZ pharmacies, by contrast, were extremely busy, yet in one case recruited few women. The lead pharmacist admitted his discomfort with the interaction around EHC, particularly in dealing with the younger women, and was reluctant to request participation in the research.
A third challenge related to confidentiality and we encountered one serious breach thereof. Despite having been briefed on the importance of ensuring confidentiality, and the importance of storing volunteer details behind the counter, staff in one pharmacy placed the box containing names on the counter, believing that women were more likely to volunteer if they felt they were not been scrutinised. On one occasion, a box containing details of up to 10 women went missing. The pharmacist notified the police and we notified the ethics committee and temporarily suspended the study at all sites pending investigation. The committee's recommendation, that the boxes be fixed to the counters at each of the sites, was not considered feasible but we proposed instead that the pharmacists should sign a document stating that the patient details would be kept locked away at all times, and that none would be left in a public area. All participating pharmacists agreed to this and the ethics committee consented to the continuation of the study, but some momentum was lost. Supported by advice from a statistician, we decided to cease recruitment at 50 women.
Ethical approval
Ethical approval for this study was granted by Guy's and St Thomas' Research Ethics Committee.
Discussion
This paper illustrates some of the challenges involved in undertaking sexual health research in pharmacies. The findings of the study, reported fully elsewhere, suggested that women experienced less privacy and comfort in pharmacies compared with those attending a clinical service. 11 This may also have impacted on the research process. Lack of experience of, and familiarity with, the research process led to difficulties of confidentiality and recruitment.
These challenges apply to all health care providers, but are exacerbated in the context of pharmacies by commercial pressures. 12 There will inevitably be incompatibility between the requirements of running a business and carrying out research. Further, at a time when pharmacists were grappling with the relatively new responsibility of EHC supply, taking on additional responsibilities of recruitment for research may have seemed overwhelming.
As researchers, we had not adequately anticipated the difficulties of maintaining control over the research process, of ensuring patient confidentiality, and of achieving compliance with the research -all of which have been reported by others. 13 Studies of emergency contraception undertaken in pharmacies have routinely achieved response rates lower than 10% 10,14-17 and this has similarly been attributed to moral opposition to EHC, time constraints, sensitivity of the issues, and unwillingness to add to the administrative burden.
Despite the difficulties, the benefits of academic research in community pharmacies can be reciprocal. Members of a community pharmacy research network established in the North of England reportedly enjoy the exposure to different research methods, and believe that involvement in research improves their relationships with customers and the advice they give. 18 Alongside the expansion of pharmacists' responsibilities, 19 professional development programmes have been set up to update them on the changing needs in pharmacy practice and to develop their clinical skills. Pharmacists are developing a broader understanding of the research process and how to interpret research findings and translate them into clinical practice. 20 Practical issues, such as lack of privacy, are being addressed. A new contractual framework for pharmacists includes provision of a consultation area as a specification for many services and as many as 75% of pharmacies now provide a private area. 21 It will take time for the necessary training in research methods to be implemented, and to influence practice. 22 Meanwhile, researchers need to ensure that the process is as convenient as possible, that it does not conflict with commercial goals, that the necessary equipment is provided, and that time is spent fully briefing pharmacists on the rationale for the procedures used. We hope that the lessons we learnt in the course of this study may benefit others. ©FSRH 
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The Faculty of Sexual and Reproductive Healthcare has available a number of annual awards for which applications are invited from Faculty members and non-members. Details of the individual awards, together with an application form and/or guidelines on how to apply and any eligibility criteria, may be found on the Faculty website at www.fsrh.org.
Margaret Jackson Prize Essay
The Faculty will award three prizes annually in memory of Dr Margaret Jackson, a distinguished pioneer in the field of family planning. These prizes are awarded to undergraduates who write the three best essays on a topic related to reproductive health care or fertility control. The first prize is £300, with £100 each for the two runners-up. Entries should not exceed 3000 words. Eligibility: Individuals (undergraduate medical students)
Closing date: 24 March annually
The David Bromham Annual Memorial Award David Bromham was the first Chairman of the Faculty of Family Planning and Reproductive Health Care (as the Faculty was then known). Sadly, halfway through his second term of office he became ill, and in 1996 he died. His loss was tragic, not only for the Faculty, but for the family planning movement in Britain and worldwide. Whilst in Leeds he set up an assisted conception programme, which was and is one of the most successful in the world. In 1991 he set up a fertility control unit designed to provide a more accessible service for the termination of pregnancy. He also carried out an extensive programme of research and was closely involved with the British Journal of Family Planning (now the Journal of Family Planning and Reproductive Health Care).
The Award is not intended to be a prize for a long and distinguished service, rather for a piece of work which through inspiration, innovation or energy has furthered the practice of family planning and reproductive health care in any way and any setting. It is not a research grant. Younger health professionals sometimes undervalue their achievements but they are exactly the people that David Bromham would have wished to see encouraged as this award now acknowledges.
The award will be made either to an individual (who must be a current Diplomate, Member or Fellow of the Faculty) or to a team, which could be multidisciplinary. In the latter case, the lead doctor should be a current member of the Faculty. You may nominate yourself or your team or be nominated by someone else.
Eligibility: Individuals (Faculty members) or teams
Closing date: 7 April annually International Travelling Scholarship of the Faculty The Faculty offers a scholarship for those Faculty members who are interested in going abroad to visit international colleagues, services, research or educational establishments in order to learn about some aspect of family planning or reproductive health care. The award will be for a maximum of £2000. The recipient of the award will be required to give a presentation at a Faculty conference. 
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